Response to 'Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable'
Mark B Faries1, Alistair J Cochran2, John F Thompson3
1The Angeles Clinic and Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
The British Journal of Dermatology
|August 21, 2022
Summary
No abstract available in PubMed .


